National Pharmaceutical Pricing Authority notifies ceiling prices of 33 drugs
Express news service :New Delhi, Jan 04 2013, 01:19 IST
The National Pharmaceutical Pricing Authority (NPPA) has notified the ceiling prices of 33 drugs as per the new pharmaceutical pricing policy.
The notification, NPPA officials say, will have only marginal impact on the prices of most of the drugs —1-2 per cent at the most — the only exception being formulations on glipizide, an oral anti-diabetic drug whose prices are likely to reduce by 20 per cent or more.
For monocomponent human insulin, prednisolone acetate ophthalmic (a drop used to treat eye allergies) and ozurdex implant (also used in some eye conditions), all imported items, there would be no change in prices.
Previous Story Govt allows clubbing fuel supplies to units of same firm Next Story Jet Air, Etihad in talks for stake sale; 24% could change hands
